» Articles » PMID: 22259690

Efficacy of Decompression and Fixation for Metastatic Spinal Cord Compression: Analysis of Factors Prognostic for Survival and Postoperative Ambulation

Overview
Date 2012 Jan 20
PMID 22259690
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goals of surgical intervention for metastatic spinal cord compression (MSCC) are prolonging survival and improving quality of life. Non-ambulatory paraplegic patients, either at presentation or after treatment, have a much shorter life expectancy than ambulatory patients. We therefore analyzed prognostic factors for survival and postoperative ambulation in patients surgically treated for MSCC.

Methods: We assessed 103 patients with surgically treated MSCC who presented with lower extremity weakness between January 2001 and December 2008. Factors prognostic for overall survival (OS) and postoperative ambulation, including surgical method, age, sex, primary tumor site, metastatic spinal site, surgical levels, Tokuhashi score, and treatment with chemo- or radiation therapy, were analyzed retrospectively.

Results: Median OS was significantly longer in the postoperatively ambulatory group [11.0 months; 95% confidence interval (CI), 9.29-12.71 months] than in the non-ambulatory group (5.0 months; 95% CI, 1.80-8.20 months) (p=0.035). When we compared median OS in patients with high (9-11) and low (0-8) Tokuhashi scores, they were significantly longer in the former (15.0 months; 95% CI, 9.29-20.71 months vs. 9.0 months; 95% CI, 7.48-10.52 months; p=0.003). Multivariate logistic regression analysis showed that preoperative ambulation with or without aid [odds ratio (OR) 5.35; 95% CI 1.57-18.17; p=0.007] and hip flexion power greater than grade III (OR 6.23; 95% CI, 1.29-7.35; p=0.038) were prognostic of postoperative ambulation.

Conclusion: We found that postoperative ambulation and preoperative high Tokuhashi score were significantly associated with longer patient survival. In addition, preoperative hip flexion power greater than grade III was critical for postoperative ambulation.

Citing Articles

Effects of sarcopenia and nutritional status on surgical outcomes for metastatic spinal tumors: In the perspective of peri-operative complications and performance improvement.

Bang C, Ko M, Ko Y, Kim Y Acta Neurochir (Wien). 2024; 166(1):423.

PMID: 39441220 DOI: 10.1007/s00701-024-06288-4.


Survival and Prognostic Factors After Surgery in Single Spinal Metastasis: Comparison of Isolated-Single Spinal Metastasis and Single Spinal Metastasis With Other Metastasis.

Kim H, Park J, Park S, Kang D, Lee C Global Spine J. 2024; :21925682241295666.

PMID: 39425906 PMC: 11559813. DOI: 10.1177/21925682241295666.


Quality of life in patients with malignant spinal cord compression: a systematic review.

Gojsevic M, Shariati S, Chan A, Bonomo P, Zhang E, Kennedy S Support Care Cancer. 2023; 31(12):736.

PMID: 38055061 DOI: 10.1007/s00520-023-08186-4.


Prognostic Factors for Bone Survival and Functional Outcomes in Patients With Breast Cancer Spine Metastases.

Qiao R, Zhang H, Ma R, Li R, Hu Y Technol Cancer Res Treat. 2022; 21:15330338221122642.

PMID: 36214255 PMC: 9551339. DOI: 10.1177/15330338221122642.


Systemic considerations for the surgical treatment of spinal metastatic disease: a scoping literature review.

MacLean M, Touchette C, Georgiopoulos M, Brunette-Clement T, Abduljabbar F, Ames C Lancet Oncol. 2022; 23(7):e321-e333.

PMID: 35772464 PMC: 9844540. DOI: 10.1016/S1470-2045(22)00126-7.


References
1.
Maranzano E, Latini P . Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys. 1995; 32(4):959-67. DOI: 10.1016/0360-3016(95)00572-g. View

2.
North R, LaRocca V, Schwartz J, North C, Zahurak M, Davis R . Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg Spine. 2005; 2(5):564-73. DOI: 10.3171/spi.2005.2.5.0564. View

3.
Zelefsky M, Scher H, Krol G, Portenoy R, Leibel S, Fuks Z . Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer. 1992; 70(9):2319-25. DOI: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8. View

4.
Melcher I, Disch A, Khodadadyan-Klostermann C, Tohtz S, Smolny M, Stockle U . Primary malignant bone tumors and solitary metastases of the thoracolumbar spine: results by management with total en bloc spondylectomy. Eur Spine J. 2007; 16(8):1193-202. PMC: 2200785. DOI: 10.1007/s00586-006-0295-5. View

5.
Eleraky M, Papanastassiou I, Vrionis F . Management of metastatic spine disease. Curr Opin Support Palliat Care. 2010; 4(3):182-8. DOI: 10.1097/SPC.0b013e32833d2fdd. View